Urologix Inc (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2004 | 06-2003 | 06-2002 | 06-2001 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 356 | -10,334 | -1,650 | -5,130 | -7,090 |
| Depreciation Amortization | 2,001 | 2,073 | 1,750 | 1,940 | 1,510 |
| Income taxes - deferred | 286 | 286 | N/A | N/A | N/A |
| Accounts receivable | -561 | 2,367 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -322 | -846 | N/A | N/A | N/A |
| Other Working Capital | 243 | 410 | -1,810 | -740 | 1,240 |
| Other Operating Activity | 889 | -1,463 | 250 | 180 | 0 |
| Operating Cash Flow | $2,892 | $-7,507 | $-1,460 | $-3,750 | $-4,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -280 | -1,380 | -870 | -480 |
| Net Acquisitions | N/A | N/A | 0 | -7,570 | 0 |
| Purchase Of Investment | N/A | -12,364 | N/A | N/A | N/A |
| Sale Of Investment | 1,352 | 19,629 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -112 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -112 | 0 | 3,820 | 8,280 | 4,200 |
| Investing Cash Flow | $1,240 | $6,985 | $2,440 | $-160 | $3,720 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -761 | -513 | N/A | N/A | N/A |
| Common Stock Issued | 1,044 | 158 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 600 | 3,490 | 420 |
| Financing Cash Flow | $283 | $-355 | $600 | $3,490 | $420 |
| Beginning Cash Position | 727 | 1,604 | 20 | 450 | 650 |
| End Cash Position | 5,142 | 727 | 1,600 | 20 | 450 |
| Net Cash Flow | $4,415 | $-877 | $1,570 | $-430 | $-190 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,892 | -7,507 | -1,460 | -3,750 | -4,340 |
| Capital Expenditure | N/A | -280 | N/A | N/A | N/A |
| Free Cash Flow | 2,892 | -7,787 | -1,460 | -3,750 | -4,340 |